---
title: "Cardiologist questions STREAM trial findings on deprescribing statins in older adults"
id: "stat-news-1-opinion-stat-i-m-a-cardiologist-i-m-a-little-puzzled-about-the-blockbuster-new"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-1-opinion-stat-i-m-a-cardiologist-i-m-a-little-puzzled-about-the-blockbuster-new"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/11/19/deprescribing-statins-study-stream-trial-aha-questions/?utm_campaign=rss"
published_at: "2026-11-19T09:30:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Cardiologist questions STREAM trial findings on deprescribing statins in older adults
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-1-opinion-stat-i-m-a-cardiologist-i-m-a-little-puzzled-about-the-blockbuster-new
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/11/19/deprescribing-statins-study-stream-trial-aha-questions/?utm_campaign=rss)
- **Published At:** 2026-11-19T09:30:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- At the American Heart Association meeting, Vishal Khetpal — a preventive cardiologist and assistant professor at Northwestern University Feinberg School of Medicine — reviewed results from the **STREAM trial** and expressed clinical skepticism about the report’s interpretation. - The trial compared continuing versus stopping **statins** in older adults without prior heart attacks or strokes; investigators reported no statistically significant difference in the primary outcome, meeting the trial’s **noninferiority** threshold as presented. - Visual inspection of the trial’s Kaplan-Meier curves showed divergence between arms, with the group that stopped statins faring worse over time; the study team observed this divergence despite the noninferiority claim. - The data safety monitoring board advised that patients who had stopped their statins should discuss resuming therapy with their clinicians, the author noted. - Khetpal recorded three specific questions raised by the trial’s results and their presentation; the source article indicates the author remained “a little puzzled” and sought clarity about interpretation. - The publicly available article did not report trial-level details such as sample size, exact endpoints, follow-up duration, dosing regimens, subgroup analyses, or statistical boundary definitions; those methodological specifics were not included in the source text. - Because the published STAT piece is partially behind a subscriber paywall, the source did not provide the author’s full set of analyses, limits, or all three questions in detail; readers were directed to the STAT+ version for the complete commentary. - Taken together, the account conveyed tension between a formal noninferiority declaration and clinically meaningful divergence in outcomes, prompting calls for clinicians to review individual patient decisions about stopping **statins**.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/2026/11/19/deprescribing-statins-study-stream-trial-aha-questions/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/11/19/deprescribing-statins-study-stream-trial-aha-questions/?utm_campaign=rss) [FDA](https://www.statnews.com/topic/fda/) [research](https://www.statnews.com/topic/research/) [HHS](https://www.statnews.com/topic/hhs/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [STAT@JPM27](https://www.statnews.com/jpm-conference-stat-events/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) My Account * [Settings](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing History](https://www.statnews.com/my-account/billing/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Trust in Science](https://www.statnews.com/trust-in-science/) * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Madness 2027](https://www.statnews.com/feature/stat-madness/apply/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) China's Biotech Powerhouse 25 We ranked the 25 most valuable publicly traded Chinese drugmakers [ See the list ](https://www.statnews.com/china-biotech-index-powerhouse-25/) [STAT Plus](https://www.statnews.com/stat-plus/)Opinion[The Workup](https://www.statnews.com/category/the-workup/) # I’m a cardiologist. I’m a little puzzled about the blockbuster new study on deprescribing statins ## Three questions about the STREAM trial * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/11/19/deprescribing-statins-study-stream-trial-aha-questions/?utm_campaign=rss) ![](https://www.statnews.com/wp-content/uploads/2025/09/TheWorkup_Illustration_MollyFerguson_093025-645x645.jpg) Molly Ferguson for STAT By Vishal Khetpal Nov. 19, 2026 Khetpal is a preventive cardiologist and assistant professor of medicine at the Northwestern University Feinberg School of Medicine. He writes [The Workup](https://www.statnews.com/category/the-workup/), a STAT column about cardiology. At the American Heart Association’s recent annual meeting, the overarching theme coming from the center stage, bathed in Pantone red, was one of [high-profile neutral findings](https://www.statnews.com/2026/11/09/aha-2026-news-neutral-clinical-trials-lessons-learned/). As I listened to the results of the [STREAM](https://www.nejm.org/doi/full/10.1056/NEJMoa2606634) trial — which found that older adults without a history of heart attacks or strokes who stopped taking statins didn’t have significantly different outcomes from those who continued taking them — I jotted down that the study continued the theme. Advertisement But as the [Kaplan-Meier curves](https://x.com/NEJM/status/2119178084322545722) were cast onto the screen, something felt off: The curves diverged, rather than stayed together. Theoretically, this scenario can happen in noninferiority studies, where researchers are testing whether an intervention offers similar outcomes compared with a standard. De-prescribing statins in this group, by the expectations set by researchers at the beginning of STREAM, was technically noninferior, but nevertheless, still inferior. The patients randomized to stop taking their statin did worse compared with those who continued. Even the trial’s data safety monitoring board suggested that patients who have stopped their statins should talk to their doctors about resuming their medications. [![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo.svg)](https://www.statnews.com/stat-plus/) To read the rest of this story subscribe to STAT+. [Subscribe](https://www.statnews.com/stat-plus/) [Log In](https://www.statnews.com/login/) [aging](https://www.statnews.com/topic/aging/), [cardiovascular disease](https://www.statnews.com/topic/cardiovascular-disease/), [Clinical trials](https://www.statnews.com/topic/clinical-trials/), [STAT+](https://www.statnews.com/topic/stat-plus/) [Submit a correction request](https://www.statnews.com/contact/?how_can_we_help_=Editorial%20Correction%20Request)[Reprints](https://www.parsintl.com/publications/stat/) 1. Vishal Khetpal 1. [](https://x.com/vishal_khetpal "X") 2. 1. [](https://x.com/vishal_khetpal "X") 2. ![](https://www.statnews.com/wp-content/themes/stat/images/article-new/envelope-open.svg) ![](https://www.statnews.com/wp-content/uploads/2023/06/First-Opinion-Logo-Black-640x319.png) ### Newsletter The smartest thinkers in life sciences on what's happening — and what's to come Please enter a valid email address. Sign Up Your data will be processed in accordance with our [Privacy Policy](https://www.statnews.com/privacy/) and [Terms of Service](https://www.statnews.com/terms-conditions/). You may opt out of receiving STAT communications at any time. Advertisement Most Popular 1. ![](https://www.statnews.com/wp-content/uploads/2026/11/image-9-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Epic Systems defends competitive practices, promises to let AI access its records](https://www.statnews.com/2026/11/18/epic-defends-competitive-practices-promises-ai-access-to-records/) 2. ![](https://www.statnews.com/wp-content/uploads/2018/10/Small-cell-lung-cancer-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA discloses reasons for rejecting Summit drug](https://www.statnews.com/2026/11/18/biotech-news-fda-discloses-reasons-for-rejecting-summit-drug/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/11/AdobeStock_1874804219-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Beyond statins, one drug lowered heart attack risk by 20%](https://www.statnews.com/2026/11/05/repatha-vs-zetia-cholesterol-study-heart-attack-risk/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/10/szy091426_longevity_07-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Can you live longer for $5,500? Longevity clinics are the buzzy new trend at nonprofit hospitals](https://www.statnews.com/2026/10/06/hospitals-longevity-clinics-healthy-aging-wellness-trend/) 5. ![](https://www.statnews.com/wp-content/uploads/2024/11/NA_STAT0057-80x80.jpg) [The recovery community says it offers refuge from opioid addiction. But it’s still hostile to lifesaving addiction medications ](https://www.statnews.com/2024/11/12/opioid-addiction-recovery-narcotics-anonymous-salvation-army/) #### [ Reports ](https://reports.statnews.com/) [ ![](https://www.statnews.com/wp-content/uploads/2026/08/2026_CancerReport_ReportCover-328x424.jpg) Explore Cancer’s transformational moments: KRAS, CAR-T, immunotherapy, and more ](https://reports.statnews.com/products/cancer-transformational-moments-advances-in-kras-car-t-immunotherapy) Advertisement #### [Events](https://www.statnews.com/events/) [ ![](https://www.statnews.com/wp-content/uploads/2026/10/STATatHLTH_Wordpress_CalendarImage-80x80.jpg) STAT@hlth. A Dose of Reality on EHRs and AI In-person Nov 18 ](https://www.statnews.com/event/stathlth-a-dose-of-reality-on-ehrs-and-ai/) [ ![](https://www.statnews.com/wp-content/uploads/2026/09/2026ASH_Wordpress_CalendarImage-80x80.jpg) STAT@ASH: Medicine’s Bleeding Edge New Orleans, LA Dec 13 ](https://www.statnews.com/event/stat-at-ash-meeting-2026/) [ ![](https://www.statnews.com/wp-content/uploads/2026/09/BTE2027_Wordpress_CalendarImage-80x80.jpg) 2027 Breakthrough Summit East New York City, NY Mar 18 ](https://www.statnews.com/event/2027-stat-breakthrough-summit-east/) Most Read in [STAT+](https://www.statnews.com/stat-plus/) 1. ![](https://www.statnews.com/wp-content/uploads/2024/09/GettyImages-1237273640-1-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA rejects lung cancer treatment ivonescimab from Summit Therapeutics](https://www.statnews.com/2026/11/15/fda-rejects-ivonescimab-lung-cancer-treatment-summit-therapeutics/) 2. ![](https://www.statnews.com/wp-content/uploads/2017/01/AP80889059-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Federal judge issues final ruling blocking U.S. plan to limit visa length for grad students, postdocs](https://www.statnews.com/2026/11/16/judge-rejects-visa-limits-international-researchers-upholds-duration-of-status-policy/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/11/AdobeStock_587333568_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [In a win for MAHA, FDA creates new regulatory category for the supplement NAC](https://www.statnews.com/2026/11/16/fda-proposes-new-category-supplement-nac/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/10/AdobeStock_391451620_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Former Eli Lilly rep claims she was fired for complaining about marketing of Mounjaro diabetes drug](https://www.statnews.com/pharmalot/2026/11/10/former-lilly-rep-claims-she-was-fired-for-complaining-about-marketing-of-mounjaro-diabetes-drug/) 5. ![](https://www.statnews.com/wp-content/uploads/2019/09/AP_060324030695-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA approves novel Bayer drug to reduce recurrence of stroke](https://www.statnews.com/2026/11/09/cardiovascular-stroke-recurrence-bayer-drug-fda-approval/) #### Recommended ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Lab Dish Lab Dish November 18, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: RFK Jr. has got to go ](https://www.statnews.com/2026/11/18/kennedy-impeachment-paul-knoepfler-says-time-is-now/) By Paul Knoepfler ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) First Opinion First Opinion November 18, 2026 ### [ Maybe in-person four-year institutions aren’t the right approach to medical education ](https://www.statnews.com/2026/11/18/core-to-clinic-medical-education-radical-proposal/) By Alex Serafini Advertisement ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) First Opinion First Opinion November 17, 2026 ### [ The problem with ‘zero tolerance for bad behavior’ signs at hospitals ](https://www.statnews.com/2026/11/17/hospital-signs-violence-health-care-workers-research-stigma/) By Autumn Fiester, Aliza Narva, and Stacy C. Smith ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) First Opinion First Opinion November 16, 2026 ### [ Medical school should start after students take the Step 1 exam ](https://www.statnews.com/2026/11/16/medical-school-step-1-exam-redesign-proposal/) By Rachel E. Fabi and Amy Caruso Brown ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Chief Complaint Chief Complaint November 16, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Candles and long baths can’t fix burned-out physicians ](https://www.statnews.com/2026/11/16/doctors-self-care-limits-literature-systems/) By Frances Mei Hardin #### Subscriber Picks 1. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: What to know about Biogen's big lupus study readout ](https://www.statnews.com/2026/11/12/biogen-lupus-litifilimab-what-to-know/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 2. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: As Epic’s dominance grows, its iron grip is choking innovation in health technology ](https://www.statnews.com/2026/10/28/epic-systems-ehr-dominance-health-tech-antitrust-scrutiny/) By [Casey Ross](https://www.statnews.com/staff/casey-ross/) and [Brittany Trang](https://www.statnews.com/staff/brittany-trang/) 3. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: After death in gene therapy trial for a brain disease, progress is reported ](https://www.statnews.com/2026/11/17/capsida-gene-therapy-trial-death-follow-up-investigation/) By [Jason Mast](https://www.statnews.com/staff/jason-mast/) 4. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Sellas' experimental blood cancer immunotherapy reduced risk of death in clinical trial ](https://www.statnews.com/2026/11/17/sellas-blood-cancer-immunotherapy-succeeds-clinical-trial/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 5. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: FDA approves new breast cancer drug, providing new option for some patients, boost for Roche ](https://www.statnews.com/2026/11/16/fda-approves-new-roche-breast-cancer-drug/) By [Andrew Joseph](https://www.statnews.com/staff/andrew-joseph/) Share options * [ X ](https://twitter.com/intent/tweet?url=https://www.statnews.com/2026/11/19/deprescribing-statins-study-stream-trial-aha-questions/&via=statnews&text=I%E2%80%99m%20a%20cardiologist.%20I%E2%80%99m%20a%20little%20puzzled%20about%20the%20blockbuster%20new%20study%20on%20deprescribing%20statins "Share on X") * [ Bluesky ](https://bsky.app/intent/compose?text=I%E2%80%99m%20a%20cardiologist.%20I%E2%80%99m%20a%20little%20puzzled%20about%20the%20blockbuster%20new%20study%20on%20deprescribing%20statins%20https://www.statnews.com/2026/11/19/deprescribing-statins-study-stream-trial-aha-questions/%20via%20@statnews.com "Share on Bluesky") * [ LinkedIn ](https://www.linkedin.com/shareArticle?url=https://www.statnews.com/2026/11/19/deprescribing-statins-study-stream-trial-aha-questions/&mini=true&source=STAT "Linkedin") * [ Facebook ](https://www.facebook.com/sharer/sharer.php?u=https://www.statnews.com/2026/11/19/deprescribing-statins-study-stream-trial-aha-questions/ "Facebook") * Email * [ Doximity ](https://www.doximity.com/inbox/conversations/new_message?url=https%3A%2F%2Fwww.statnews.com%2F2026%2F11%2F19%2Fdeprescribing-statins-study-stream-trial-aha-questions%2F&subject=I%E2%80%99m%20a%20cardiologist.%20I%E2%80%99m%20a%20little%20puzzled%20about%20the%20blockbuster%20new%20study%20on%20deprescribing%20statins "Doximity") * Copy link * [ Reprints ](https://www.parsintl.com/publications/stat/ "Reprints") [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Reporting from the frontiers of health
## Related Clinical Research

- [Novartis and Novo Nordisk cardiovascular trial failures and their impact on investment](https://medichelpline.com/clinical-feed/stat-news-1-stat-novartis-novo-nordisk-drug-failures-will-likely-pop-a-hole-in-the-balloon.md)
- [Exercise Prescriptions for Concussion Recovery: An Urgent Call to Action](https://medichelpline.com/clinical-feed/stat-news-2-opinion-more-doctors-should-prescribe-exercise-after-a-concussion.md)
- [Waist circumference predicts mortality more than BMI in adults 65+: study findings](https://medichelpline.com/clinical-feed/medical-news-today-0-bmi-vs-waist-size-study-finds-belly-fat-matters-more-than-weight-for-death-risk.md)
- [U.S. POINTER: Structured lifestyle program slows brain aging and cardiometabolic risk over 24 mont](https://medichelpline.com/clinical-feed/medical-news-today-0-combining-physical-mental-and-social-habits-slows-brain-aging-in-2-year-trial.md)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.